© Reuters. A sign rests on a counter at a Walgreens pharmacy store in Austin, Texas
(Reuters) – Walgreens Boots Alliance (NASDAQ:) Inc beat analysts’ estimates for adjusted quarterly profit on Thursday, driven by higher sales at its retail pharmacy stores and higher prescription volumes, sending its shares up 3.4% in premarket trading.
The company has taken a number of steps to boost profit after the COVID-19 pandemic hammered sales and forced it to cut jobs, shut some UK-based Boots stores and sell its distribution unit to AmerisourceBergen (NYSE:) Corp for $6.5 billion.
Excluding items, the company earned $1.22 per share, while analysts were expecting a profit of $1.03 per share, according to Refinitiv IBES.
Net loss attributable to Walgreens was $308 million, or 36 cents per share, in the first quarter ended Nov. 30, compared with a profit of $845 million, or 95 cents per share, a year earlier.
Revenue rose to $36.31 billion from $34.34 billion.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.